RapidAI is the trusted leader in deep clinical AI, helping hospitals deliver faster, more informed care through intelligent imaging and integrated workflows. The Rapid Enterprise™ Platform supports disease states across the care spectrum, but it’s our clinical depth that drives the most meaningful impact — improving decision-making, patient outcomes, and health-system performance. Used by more than 2,500 hospitals in over 100 countries and backed by 700+ clinical studies, including research that helped expand national stroke-treatment guidelines, RapidAI is the most clinically validated AI platform in healthcare.
Come join the RapidAI Sales team as an Account Executive reporting to the Regional VP where you will oversee the sales activities within your assigned accounts.
RapidAI is the most-widely used advanced imaging software among physicians for neurovascular-patient care, research, and clinical trials. It is the only clinically-validated intracranial imaging platform available today and considered by many to be the gold standard for advanced cerebrovascular imaging.
We are targeting candidates in East Coast (USA).
Compensation - The base salary target for the role described in this job description is $125,000. This position may also be eligible for additional incentives such as equity awards, short-term incentives, and sales commission. Total potential compensation for this position is targeted at $300,000.
RapidAI is not using recruitment agencies for this opportunity.
RapidAI is committed to creating an inclusive and diverse workplace. We provide equal employment opportunities to all employees and applicants and prohibit discrimination and harassment of any type in regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.
Please review our CPRA policies
here.
For more information on the information we collect about our applicants and how we use it, see our CPRA Privacy Notice
here.